CMF
FLGT icon

Counterpoint Mutual Funds’s Fulgent Genetics FLGT Stock Holding History

Counterpoint Mutual Funds’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$704K Hold
34,306
– – 0.07% 117
2026
Q1 		$545K Buy
34,306
+15,056
+78% +$327K 0.08% 167
2025
Q4 		$506K Buy
+19,250
New +$499K 0.04% 111
2023
Q4 		– Sell
-7,257
Closed -$194K – 174
2023
Q3 		$194K Buy
+7,257
New +$248K 0.16% 61
2023
Q2 		– Sell
-6,380
Closed -$199K – 367
2023
Q1 		$199K Buy
6,380
+1,326
+26% +$42.7K 0.17% 32
2022
Q4 		$151K Buy
+5,054
New +$181K 0.16% 94

Other funds holding FLGT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Counterpoint Mutual Funds's FLGT Position: Q2 2026 in Review

Counterpoint Mutual Funds held its Fulgent Genetics (FLGT) position steady in Q2 2026 at 34,306 shares worth $704K. The position accounts for 0.07% of the portfolio, ranked #117.

Counterpoint Mutual Funds first reported a position in FLGT in Q4 2022 and has held it in 6 quarters since. 142 funds tracked by Wall St. Rank hold FLGT as of Q2 2026.

  • Counterpoint Mutual Funds held 34,306 shares of Fulgent Genetics worth $704K as of Q2 2026.
  • Counterpoint Mutual Funds left its Fulgent Genetics share count unchanged in Q2 2026.
  • Fulgent Genetics made up 0.07% of Counterpoint Mutual Funds's portfolio in Q2 2026, its #117 holding.
  • Counterpoint Mutual Funds first reported a position in Fulgent Genetics in Q4 2022 and has held it in 6 quarters since.
  • 142 funds tracked by Wall St. Rank held Fulgent Genetics as of Q2 2026.

Based on Counterpoint Mutual Funds's 13F filing for Q2 2026, filed 20 Jul 2026.